Luisa Chocarro

Irunlarrea St, 3
Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Journal: Translational oncology

Published: January 21, 2026

PD-1/LAG-3 signaling rewires T-cells via MYC inhibition.

PD-1/LAG-3 signaling rewires T-cells via MYC inhibition.

Journal: Signal transduction and targeted therapy

Published: September 12, 2025

Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.

Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.

Journal: Cancers

Published: March 10, 2025

Fractalkine in Health and Disease.

Fractalkine in Health and Disease.

Journal: International journal of molecular sciences

Published: June 18, 2024

PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets.

Journal: EMBO molecular medicine

Published: January 12, 2024

Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.

Journal: British journal of cancer

Published: June 19, 2023

Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer.

Journal: International journal of molecular sciences

Published: February 17, 2023

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors.

Journal: International journal of molecular sciences

Published: December 22, 2022

Cutting-Edge CAR Engineering: Beyond T Cells.

Cutting-Edge CAR Engineering: Beyond T Cells.

Journal: Biomedicines

Published: October 29, 2022

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.

Journal: Nature metabolism

Published: October 25, 2022

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.

Journal: International journal of molecular sciences

Published: September 13, 2022

Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.

Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination.

Journal: Cancers

Published: August 17, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026